Fernwood Investment Management, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Fernwood Investment Management, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$6,213,299
+50.6%
235,620
-1.8%
2.23%
+52.6%
Q2 2023$4,126,194
+5.0%
239,895
+1.2%
1.46%
-3.0%
Q1 2023$3,929,046
+154.0%
236,975
+16.7%
1.51%
+135.6%
Q4 2022$1,546,860
-23.9%
203,000
-0.8%
0.64%
-25.3%
Q3 2022$2,033,000
+21.7%
204,550
+11.2%
0.86%
+19.0%
Q2 2022$1,670,000
-4.5%
183,900
+6.7%
0.72%
+17.3%
Q1 2022$1,749,000
-35.8%
172,325
+5.5%
0.61%
-31.2%
Q4 2021$2,726,000
-63.2%
163,400
+3.5%
0.89%
-64.9%
Q3 2021$7,401,000
-21.0%
157,898
+2.8%
2.54%
-17.9%
Q2 2021$9,368,000
+0.7%
153,672
+1.7%
3.10%
-9.5%
Q1 2021$9,307,000
-13.2%
151,085
+0.2%
3.42%
-19.0%
Q4 2020$10,726,000
+98.7%
150,835
+4.9%
4.23%
+65.8%
Q3 2020$5,397,000
+14.1%
143,835
-0.9%
2.55%
+9.0%
Q2 2020$4,732,000
+58.0%
145,100
+40.5%
2.34%
+22.3%
Q1 2020$2,994,000
-18.2%
103,250
-1.1%
1.91%
+9.3%
Q4 2019$3,659,000
+79.0%
104,400
+9.7%
1.75%
+72.8%
Q3 2019$2,044,00095,2001.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,835,722$103,449,00044.18%
Kohlberg Kravis Roberts & Co. L.P. 36,900,661$995,211,00012.26%
SC US (TTGP), LTD. 2,544,738$68,632,0004.69%
Cormorant Asset Management, LP 2,780,885$75,000,0004.31%
Perceptive Advisors 6,706,268$180,868,0004.15%
VIKING GLOBAL INVESTORS LP 26,620,991$717,968,0003.22%
Hillhouse Capital Management 2,035,790$54,905,0001.75%
Alpine Group USVI, LLC 20,000$539,0001.70%
HHLR ADVISORS, LTD. 2,352,900$63,458,0001.42%
SCGE MANAGEMENT, L.P. 588,235$15,865,0000.79%
View complete list of BRIDGEBIO PHARMA INC shareholders